Comments for ACEL - Stockpickr! Your Source for Stock Ideas

Comments for ACEL

Added By	Comments	Type	Date Added
littleher	This looked promising, then went straight down and hasn't shown any hope of progress in its studies. Failing clinical trials.	Hate	October 09, 2007
stacyspicks	This biotech company will be offering up their cure for a number of cancer types. They are in their third stage of approval with the FDA.	Love	July 19, 2007
victor713	small cap	Love	May 13, 2007
Raven	Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. The company has three product candidates in clinical development. Vanda's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia and bipolar disorder and has recently completed its Phase III program in schizophrenia. Vanda's second product candidate, VEC-162, is a compound for the treatment of sleep and mood disorders which is currently in Phase III for insomnia. Vanda's third product candidate, VSF-173, is a compound for the treatment of excessive sleepiness that is in a Phase II clinical trial.	Love	April 28, 2007
angelo	pharma stock with potentails	Love	January 20, 2007
winston o boogie	felt lucky	Love	January 14, 2007